Left ventricular reverse remodeling in patients with anterior wall ST-segment elevation acute myocardial infarction

Marek Grabka1, Magdalena Kocierz-Woźnowska2, Maciej Wybraniec1

  • 11 Department of Cardiology, Upper Silesian Medical Centre, Katowice, Poland.

Insights

Left ventricular reverse remodeling occurred in 37.5% of anterior ST-elevation myocardial infarction patients. Lower troponin and ST-segment elevation levels predicted this favorable remodeling, which was associated with fewer adverse events.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Interventional Cardiology

Background:

  • Anterior ST-segment elevation myocardial infarction (STEMI) can lead to significant left ventricular (LV) dysfunction.
  • Left ventricular reverse remodeling (LVRR) is a beneficial process that can improve outcomes after myocardial infarction.
  • Understanding the prevalence, predictors, and prognostic implications of LVRR in anterior STEMI is crucial for patient management.

Purpose of the Study:

  • To determine the prevalence of LVRR in patients following anterior STEMI.
  • To identify predictors of LVRR in this patient population.
  • To evaluate the impact of LVRR on long-term major adverse cardiovascular events (MACE).

Main Methods:

  • An observational study involving 40 patients with first-ever anterior STEMI.
  • LVRR defined as a reduction in left ventricular end-systolic volume (ΔLVESV) ≥ 10% at 3-month follow-up.
  • Utilized 3D transthoracic echocardiography (3D-TTE) and cardiac magnetic resonance (CMR) for imaging; patients were followed for a median of 3.4 years for MACE.

Main Results:

  • LVRR was observed in 37.5% of patients at 3-month follow-up.
  • Predictors of LVRR included lower troponin levels, lower ST-segment elevation (pre- and post-PCI), lower maximal ST-segment elevation post-PCI, lower wall motion score index, and more negative anterior wall global longitudinal strain.
  • Nine MACE occurred exclusively in the group without reverse remodeling, suggesting a potential protective effect.

Conclusions:

  • LVRR develops in a significant proportion of anterior STEMI patients, even with optimal revascularization and pharmacotherapy.
  • The study suggests LVRR may be associated with a better long-term prognosis, although this requires further investigation.
  • Additional research is needed to fully elucidate the prognostic role of LVRR in predicting adverse cardiovascular events.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
975
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
325
Nucleosome Remodeling02:54

Nucleosome Remodeling

Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
11.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
427
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
268
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
288